Globus MedicalMEX:GMED 92 Days Payable is 39.45 as of Mar. 2026, which is 4% above its 10-year median of 38.06. GuruFocus rates MEX:GMED with a GF Score™ of 92/100 and a GF Value™ of MXN1,897.96 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 793 Medical Devices & Instruments companies, Globus Medical ranks worse than 81.97% on this metric.
The historical rank and industry rank for Globus Medical's Days Payable or its related term are showing as below:
MEX:GMED'
s Days Payable Range Over the Past 10 Years
Min: 23.23 Med: 38.06 Max: 58.31
Current: 32.96
During the past 13 years, Globus Medical's highest Days Payable was 58.31. The lowest was 23.23. And the median was 38.06.
MEX:GMED's Days Payable is ranked worse than 81.97% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs MEX:GMED: 32.96
Globus Medical's Days Payable
increased
from Mar. 2025 (34.96) to Mar. 2026 (39.45).
It may suggest that Globus Medicaldelayed paying its suppliers.
Globus Medical Days Payable Related Terms
Globus Medical Days Payable Historical Data
* Premium members only.
The historical data trend for Globus Medical's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:GMED vs PEN, PODD, BRKR: Days Payable Comparison
For the Medical Devices subindustry, Globus Medical's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Globus Medical Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Days Payable distribution charts can be found below:
* The bar in red indicates where Globus Medical's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Globus Medical's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Globus Medical (MEX:GMED) has a Days Payable of 39.45 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Globus Medical and its competitors. This is near median its historical median of 38.06. Over the past decade, Globus Medical's Days Payable has ranged from 23.23 to 58.31. According to the industry distribution chart, Globus Medical ranks #650 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 82%.
Is Globus Medical's Days Payable too high?
Globus Medical's current Days Payable of 39.45 is near median its 10-year median of 38.06. Over the past 10 years, this metric has ranged from a low of 23.23 to a high of 58.31. The Medical Devices & Instruments industry median Days Payable is 67.87. Globus Medical's value of 39.45 is 41.9% below this industry median. Based on the distribution chart, Globus Medical ranks #650 out of 793 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Globus Medical has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Days Payable compare to PEN and PODD?
According to the Medical Devices & Instruments industry distribution chart, Globus Medical ranks #650 out of 793 companies for Days Payable. This places Globus Medical in the lower half of its industry. The industry median Days Payable is 67.87. Globus Medical's value of 39.45 is 41.9% below this benchmark. Historically, Globus Medical's own Days Payable has ranged from 23.23 to 58.31 over the past decade. While the company's 10-year median is 38.06 vs. the industry median of 67.87, Globus Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Globus Medical's current Days Payable of 39.45 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Globus Medical and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Globus Medical's current Days Payable is 39.45, which is near median its own 10-year median of 38.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,897.96, compared to a current price of MXN1,465.00 — trading 22.8% below its estimated fair value. The current Days Payable is 39.45, which is near median its 10-year median of 38.06 and 41.9% below the Medical Devices & Instruments industry median of 67.87. Globus Medical's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Days Payable is 39.45 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Globus Medical (MEX:GMED) Overvalued in 2026?
Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued.
The current stock price of MXN1,465.00 is trading 22.8% below its estimated GF Value™ of MXN1,897.96.
GuruFocus considers Globus Medical to be Modestly Undervalued.
Key valuation signals for MEX:GMED:
Days Payable: 39.45 (near median its 10-year median of 38.06)
GF Value™: MXN1,897.96 vs. price of MXN1,465.00 (22.8% below fair value)
Industry Position: 41.9% below the Medical Devices & Instruments median (#650 of 793)
No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
92GF Score
Get the complete analysis for MEX:GMED
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:GMED has been successfully added to your 
